Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Novonesis AS Director's Dealing 2020

Oct 22, 2020

3377_rns_2020-10-22_29334eac-7592-4dda-beb5-72371bf6ba14.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

img-0.jpeg

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Details of the person discharging managerial responsibilities/person closely associated

Name Claus Crone Fuglsang

Reason for notification

Position/status CSO and Executive Vice President, Research & Development
Initial notification/amendment Initial notification

Details of the issuer

Entity Novozymes A/S
LEI code 529900T6WNZXD2R3JW38

Details of the transaction(s)

Description:
Financial instrument Shares
Identification code ISIN DK0060336014
Nature of the transaction Shares purchased
Place(s) of transaction(s), price(s) and volume(s) Price(s)
--- ---
See appendix
Aggregated information Number of shares: 2,110
Average price, DKK: 387.93
Transaction value, DKK: 818,525.60
--- ---
Date of the transaction 2020-22-10

October 22, 2020

Company announcement No. 59

Contact information

[email protected]

Tobias Cornelius Björklund

+45 3077 8682

[email protected]

Carl Ahlgren

+1 919 702 6144

[email protected]

Ulrik Wu Svare

+45 3077 3187

[email protected]

Novozymes A/S

Novozymes A/S

Krog shoejvej 36

2880 Bagsvaerd

Denmark

Phone: +45 4446 0000

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com


Trading by management and close relations of management. Company announcement No. 59
2/2

Appendix

Date & Time Volume Price
10-22-2020 00:00 902 388.00
10-22-2020 00:00 438 388.00
10-22-2020 00:00 641 387.90
10-22-2020 00:00 129 387.30

Rethink Tomorrow
novozymes